Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Filings indexed 192 across all filing types
Latest filing 2019-07-24 Director's Dealing
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider trading or changes in shareholdings by company directors and major shareholders. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2019-07-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the acquisition of shares by a major shareholder (Hong Sung-han) of BC World Pharm. This type of filing is specifically designed to report changes in significant share ownership levels, which corresponds to the 'Major Shareholding Notification' category.
2019-07-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (insider transactions/acquisitions). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-07-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership changes of major shareholders and special related parties (insiders) of BC World Pharm. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-05-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (insider transactions/acquisitions). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-05-15 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for BC World Pharm, covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial information, business operations, capital structure, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.